Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovaBridge Biosciences (NBP) Preferred Stock Liabilities (2018 - 2019)

NovaBridge Biosciences (NBP) has disclosed Preferred Stock Liabilities for 2 consecutive years, with $440.4 million as the latest value for Q4 2019.

  • Quarterly Preferred Stock Liabilities rose 4.45% to $440.4 million in Q4 2019 from the year-ago period, while the trailing twelve-month figure was $440.4 million through Dec 2019, up 4.45% year-over-year, with the annual reading at $449.6 million for FY2019, 6.62% up from the prior year.
  • Preferred Stock Liabilities for Q4 2019 was $440.4 million at NovaBridge Biosciences, up from $421.6 million in the prior quarter.
  • The five-year high for Preferred Stock Liabilities was $440.4 million in Q4 2019, with the low at $421.6 million in Q4 2018.